Azoles
eMolecules 4-(1,3,4-Oxadiazol-2-yl)phenol | 5378-27-8 | MFCD00221056 | 1g
Combi-Blocks | 4-(1,3,4-Oxadiazol-2-yl)phenol | 1g | 117568897 | ST-2112 | 98.000 | 5378-27-8 | MFCD00221056 | 162.148 | C8H6N2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules ChemScene / 134-Oxathiazinane 33-dioxide / 100mg / 415477351 / CS-0057466 / 0.000 / 863015-82-1 / MFCD09953728 / 137.150 / C3H7NO3S
ChemScene / 134-Oxathiazinane 33-dioxide / 100mg / 415477351 / CS-0057466 / 0.000 / 863015-82-1 / MFCD09953728 / 137.150 / C3H7NO3S
eMolecules AstaTech / 5-(PYRIDIN-3-YL)-134-THIADIAZOL-2-AMINE / 0.1g / 226993672 / 68120 / 95.000 / 68787-52-0 / MFCD00469439 / 178.210 / C7H6N4S
AstaTech / 5-(PYRIDIN-3-YL)-134-THIADIAZOL-2-AMINE / 0.1g / 226993672 / 68120 / 95.000 / 68787-52-0 / MFCD00469439 / 178.210 / C7H6N4S
eMolecules 4-(1,3,4-Oxadiazol-2-yl)benzoic acid | 59663-66-0 | 1G | Purity: 95%
Combi-Blocks | 4-(1,3,4-Oxadiazol-2-yl)benzoic acid | 1G | 59663-66-0 | MFCD07352166
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC 6-Bromo-2-(bromomethyl)-3-fluoropyridine | 1187836-89-0 | 96.8% | 268.91 | 25 MG
6-Bromo-2-(bromomethyl)-3-fluoropyridine is a biological molecule intended for research use only. This compound is a white to off-white solid with a molecular formula of C6H4Br2FN and a molecular weight of 268.91.
- Purity of 96.79%
- Store at 4°C, protected from light
- Soluble in DMSO at 100 mg/mL
Medchemexpress LLC 1-Bromo-4-(bromomethyl)benzene-d6 (α,4-Dibromotoluene-d6) | 229948-68-9 | 99.6% | C7D6Br2 | 25 MG
1-Bromo-4-(bromomethyl)benzene-d6 is a deuterium labeled compound, useful as a tracer or internal standard for quantitative analysis. Deuteration can influence pharmacokinetic and metabolic profiles of drugs, making this product valuable for drug development research.
- Can be used as a tracer
- Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Deuteration can affect the pharmacokinetic and metabolic profiles of drugs
- For research use only
eMolecules Medchem Express / PSN 375963 / 5mg / 601586505 / HY-108258 / / 388575-52-8 / MFCD01829706 / 285.391 / C17H23N3O
Medchem Express / PSN 375963 / 5mg / 601586505 / HY-108258 / / 388575-52-8 / MFCD01829706 / 285.391 / C17H23N3O
Medchemexpress LLC 1-Bromo-4-(bromomethyl)benzene-d6 | 229948-68-9 | 99.6% | C7D6Br2 | 5 MG
1-Bromo-4-(bromomethyl)benzene-d6 is the deuterium labeled 1-Bromo-4-(bromomethyl)benzene. It can be used as a tracer or as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS. Deuterium substitution can impact the pharmacokinetic and metabolic profiles of drugs.
- Deuterium labeled compound
- Used as a tracer or internal standard
- Suitable for quantitative analysis by NMR, GC-MS, or LC-MS
- Impacts pharmacokinetic and metabolic profiles of drugs
Medchemexpress LLC PSN 375963 10mg | 388575-52-8 | 10MG
PSN 375963 is a potent GPR119 agonist with EC50s of 8 4 and 7 9 M for human and mouse GPR119 respectively PSN 375963 shows similar potency to the endogenous agonist oleoylethanolamide (OEA)[1 [2
Apexbio Technology LLC ODQ 41443-28-1 10mg
ODQ (CAS 41443-28-1) is a selective inhibitor of soluble guanylate cyclase (sGC) interfering with nitric oxide (NO)-dependent intracellular signaling by blocking sGC-mediated catalysis of cyclic guanosine monophosphate (cGMP) synthesis This inhibition results in reduced cGMP production and subsequent modulation of protein kinase G-regulated cellular processes Studies have demonstrated that ODQ enhances cisplatin-induced apoptosis in human mesothelioma cells in vitro supporting its use in investigating tumor cell apoptosis mechanisms and evaluating synergistic effects in anticancer drug research